HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Moore, J. K. Articles by Bellgrau, D. Search for Related Content PubMed PubMed Citation Articles by Moore, J. K. Articles by Bellgrau, D. Pubmed/NCBI databases Substance via MeSH Medline Plus Health Information Diabetes Type 1

The Identification of a Novel T Cell Activation State Controlled by a Diabetogenic Gene¹

Jodene K. Moore^*, Robert I. Scheinman and Donald Bellgrau^2,*

^* Department of Immunology, Barbara Davis Center for Childhood Diabetes, School of Medicine and Department of Pharmaceutical Sciences, School of Pharmacy, University of Colorado Health Sciences Center, Denver, CO 80262

The cyclin-dependent kinase inhibitor p27^kip regulates the cell cycle at the G₁-S phase restriction point. S phase entry and cell cycle commitment in peripheral T cells requires p27^kip degradation, normally initiated by the receipt of costimulatory signals such as those provided by B7.1 or IL-2. We have previously reported that T cells from BioBreeding (BB)-diabetes-prone (DP) rats exhibit decreased costimulatory requirements for activation and cell cycle entry. In the present study, we find that peripheral T cell subsets from BB-DP rats demonstrate activation-like characteristics, including significantly reduced levels of p27^kip as well as increased levels of proliferating cell nuclear Ag (PCNA). Since our previous studies have established that expression of extracellular activation markers are relatively low in unmanipulated peripheral BB-DP T cells; this p27^low PCNA^high phenotype represents a novel activation state. Analyses of T cell subsets from congenic rats demonstrate that this phenotype segregates with the lyp diabetogenic locus and that the p27^low PCNA^high phenotype is T cell specific. This p27^low PCNA^high phenotype is not seen in medullary thymocytes, but appears abruptly in the recent thymic emigrant population, suggesting that the lyp locus does not act directly on cell cycle regulators but rather alters the interaction between T cells and the peripheral environment. These results provide a biochemical basis for costimulation-independent activation and suggest a mechanism whereby a diabetes susceptibility gene contributes to disease development.

This article has been cited by other articles:

				C. Dion, C. Carter, L. Hepburn, W. J. Coadwell, G. Morgan, M. Graham, N. Pugh, G. Anderson, G. W. Butcher, and J. R. Miller Expression of the Ian family of putative GTPases during T cell development and description of an Ian with three sets of GTP/GDP-binding motifs Int. Immunol., September 1, 2005; 17(9): 1257 - 1268. [Abstract] [Full Text] [PDF]

				P. P. L. Chiu, A. M. Jevnikar, and J. S. Danska Genetic Control of T and B Lymphocyte Activation in Nonobese Diabetic Mice J. Immunol., December 15, 2001; 167(12): 7169 - 7179. [Abstract] [Full Text] [PDF]